Can-Fite BioPharma Ltd. (TLV:CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.000
0.00 (0.00%)
Aug 14, 2025, 2:07 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 43.72 million as of August 14, 2025. Its market cap has decreased by -43.85% in one year.
Market Cap
43.72M
Enterprise Value
15.37M
Revenue
2.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 43.72M, an increase of 172.59%. That is a compound annual growth rate of 5.37%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 64.35B |
| Danel (Adir Yeoshua) | 2.50B |
| Kamada | 1.43B |
| Bait Bakfar | 1.06B |
| SofWave Medical | 977.04M |
| BrainsWay | 772.64M |
| Novolog (Pharm-Up 1966) | 709.61M |
| Ilex Medical | 673.41M |